Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

IMMUNOCORE LIMITED

Company number 06456207

Follow this company File for this company

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
19 Dec 2023 CS01 Confirmation statement made on 18 December 2023 with no updates
10 Jun 2023 AA Full accounts made up to 31 December 2022
21 Dec 2022 CS01 Confirmation statement made on 18 December 2022 with no updates
16 Nov 2022 MR04 Satisfaction of charge 064562070004 in full
10 Nov 2022 MR01 Registration of charge 064562070007, created on 8 November 2022
10 Nov 2022 MR01 Registration of charge 064562070008, created on 8 November 2022
10 Nov 2022 MR01 Registration of charge 064562070009, created on 8 November 2022
08 Nov 2022 MR01 Registration of charge 064562070005, created on 8 November 2022
08 Nov 2022 MR01 Registration of charge 064562070006, created on 8 November 2022
15 Jul 2022 AA Full accounts made up to 31 December 2021
15 Mar 2022 AP01 Appointment of Tina St Leger as a director on 10 March 2022
06 Jan 2022 TM01 Termination of appointment of Francoise Pauline Webster as a director on 5 January 2022
21 Dec 2021 CS01 Confirmation statement made on 18 December 2021 with updates
19 May 2021 AAMD Amended group of companies' accounts made up to 31 December 2020
18 May 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 15 January 2021
  • GBP 641.4512
17 May 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 15 January 2021
  • GBP 639.5252
13 May 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 21 December 2020
  • GBP 638.1510
12 May 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 21 December 2020
  • GBP 625.3617
11 May 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 19 October 2020
  • GBP 542.9898
06 May 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 3 September 2020
  • GBP 542.9651
28 Apr 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 24 June 2020
  • GBP 542.9421
28 Apr 2021 AA Group of companies' accounts made up to 31 December 2020
23 Apr 2021 RP04SH01 Second filing of a statement of capital following an allotment of shares on 19 March 2020
  • GBP 542.8480
04 Feb 2021 PSC05 Change of details for Immunocore Holdings Limited as a person with significant control on 1 February 2021
04 Feb 2021 SH06 Cancellation of shares. Statement of capital on 3 March 2020
  • GBP 542.9421